Fig. 1From: Trastuzumab immunogenicity development in patients’ sera and in laboratory animalsAnti-trastuzumab antibody levels developed in mice injected with different concentrations of trastuzumab. Control group, mice injected with only normal saline; group I, mice injected with 14.8 mg trastuzumab/kg body weight; group II, mice injected with 74 mg trastuzumab/kg body weight; group III, mice injected with 148 mg trastuzumab/kg body weightBack to article page